Paul Tudor Jones's COGT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 159,942 shares of Cogent Biosciences, Inc. (COGT) worth $5.68 M, representing 0.01% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in COGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 159,942 shares. Largest reduction occurred in Q1 2024, reducing 58,031 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Cogent Biosciences (COGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cogent Biosciences (COGT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +159,942 | New Buy | 159,942 | $35.52 |
| Q2 2025 | -42,722 | Sold Out | 0 | $0.00 |
| Q1 2025 | +25,903 | Add 154.01% | 42,722 | $5.99 |
| Q4 2024 | +16,819 | New Buy | 16,819 | $7.80 |
| Q3 2024 | -42,532 | Sold Out | 0 | $0.00 |
| Q2 2024 | +42,532 | New Buy | 42,532 | $8.43 |
| Q1 2024 | -58,031 | Sold Out | 0 | $0.00 |
| Q4 2023 | +11,060 | Add 23.55% | 58,031 | $5.88 |
| Q3 2023 | +30,543 | Add 185.92% | 46,971 | $9.75 |
| Q2 2023 | -23,645 | Reduce 59.00% | 16,428 | $11.84 |
| Q1 2023 | +5,467 | Add 15.80% | 40,073 | $0.01 |
| Q4 2022 | +34,606 | New Buy | 34,606 | $0.01 |
Paul Tudor Jones's Cogent Biosciences Investment FAQs
Paul Tudor Jones first purchased Cogent Biosciences, Inc. (COGT) in Q4 2022, acquiring 34,606 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Cogent Biosciences, Inc. (COGT) for 12 quarters since Q4 2022.
Paul Tudor Jones's largest addition to Cogent Biosciences, Inc. (COGT) was in Q4 2025, adding 159,942 shares worth $5.68 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 159,942 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $5.68 M.
As of the Q4 2025 filing, Cogent Biosciences, Inc. (COGT) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Cogent Biosciences, Inc. (COGT) was 159,942 shares, as reported at the end of Q4 2025.